Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Wax

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Arthritis and Rheumatism|February 7, 2003
Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcriptsStephen Wax, Monica Piecyk, Beatrice Maritim, et al.
Best Practice & Research. Clinical Rheumatology|April 8, 2026
T-cell engagers in rheumatologyAlberto Nordmann-Gomes, Leila Khalili, Stephen Wax, et al.
International Reviews of Immunology|February 21, 2017
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseasesEileen Samy, Stephen Wax, Bertrand Huard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRILCaroline Gordon, David Wofsy, Stephen Wax, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis Research & Therapy|February 14, 2012
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trialEllen M Ginzler, Stephen Wax, Anand Rajeswaran, et al.
The EMBO Journal|March 12, 2004
MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decayGeorg Stoecklin, Tiffany Stubbs, Nancy Kedersha, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb StudyJoan T Merrill, Daniel J Wallace, Stephen Wax, et al.
Pharmacology Research & Perspectives|December 17, 2021
Metopimazine is primarily metabolized by a liver amidase in humansRobert W Busby, Xiaokun Cai, Sihyung Yang, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Arthritis and Rheumatism|February 7, 2003
Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcriptsStephen Wax, Monica Piecyk, Beatrice Maritim, et al.
Best Practice & Research. Clinical Rheumatology|April 8, 2026
T-cell engagers in rheumatologyAlberto Nordmann-Gomes, Leila Khalili, Stephen Wax, et al.
International Reviews of Immunology|February 21, 2017
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseasesEileen Samy, Stephen Wax, Bertrand Huard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRILCaroline Gordon, David Wofsy, Stephen Wax, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis Research & Therapy|February 14, 2012
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trialEllen M Ginzler, Stephen Wax, Anand Rajeswaran, et al.
The EMBO Journal|March 12, 2004
MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decayGeorg Stoecklin, Tiffany Stubbs, Nancy Kedersha, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb StudyJoan T Merrill, Daniel J Wallace, Stephen Wax, et al.
Pharmacology Research & Perspectives|December 17, 2021
Metopimazine is primarily metabolized by a liver amidase in humansRobert W Busby, Xiaokun Cai, Sihyung Yang, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Pageof 2